Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 6/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CDC42 | P60953 | 1/20 | 0.54 |
| ▸ | RAC1 | P63000 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | CA4 | P22748 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1395949 | 1.00 | PTGS2 (0.65) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL13484161 | 0.98 | PTGS2 (0.65) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL13592731 | 0.90 | TDP1 (0.69) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL16193388 | 0.86 | PTGS2 (0.65) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL12744212 | 0.86 | PTGS2 (0.65) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL13089018 | 0.85 | PTGS2 (0.63) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL1395995 | 0.85 | PTGS2 (0.63) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL1395993 | 0.85 | PTGS2 (0.63) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL9239307 | 0.85 | PTGS2 (0.66) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 | |
| SCHEMBL9289868 | 0.85 | PTGS2 (0.66) | PTGS2TDP1L3MBTL1PTGS1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329937-B2 | Method for purifying 4-(nitrooxy)butyl(2S)-2-(6-methoxy-2-naphthyl) propanoate | NICOX S.A. (FR) | 2012-12-11 | — | — | US | disclosed |
| US-8329937-B2 | Method for purifying 4-(nitrooxy)butyl(2S)-2-(6-methoxy-2-naphthyl) propanoate | NICOX S.A. (FR) | 2012-12-11 | — | — | US | disclosed |
| US-20100256411-A1 | METHOD FOR PURIFYING 4-(NITROOXY)BUTYL(2S)-2-(6-METHOXY-2-NAPHTHYL) PROPANOATE | NICOX S.A. (FR) | 2010-10-07 | — | — | US | disclosed |
| US-20100256411-A1 | METHOD FOR PURIFYING 4-(NITROOXY)BUTYL(2S)-2-(6-METHOXY-2-NAPHTHYL) PROPANOATE | NICOX S.A. (FR) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256411-A1 | METHOD FOR PURIFYING 4-(NITROOXY)BUTYL(2S)-2-(6-METHOXY-2-NAPHTHYL) PROPANOATE | NAPEPLD, PNPO, NRDC | PTGS2 60/4885TDP1 1591/4885L3MBTL1 4869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.